CVS Caremark (CVS) was upgraded by BMO (BMO) to outperform from market perform with a price target of $53 due to the expectation of higher earnings and improved margins during the next several quarters. Shares are higher by about 3.2 percent.
CVS Caremark (CVS) was upgraded by BMO (BMO) to outperform from market perform with a price target of $53 due to the expectation of higher earnings and improved margins during the next several quarters. Shares are higher by about 3.2 percent.
